Clinical Trial Update: An Observational Study of Mircera (Methoxy Polyethylene Glycol-epoetin Beta) in Anemic Patients With Chronic Kidney Disease (NORM)

View source ↗

Summary

An observational study (NORM) evaluating Mircera (methoxy polyethylene glycol-epoetin beta) in anemic patients with chronic kidney disease has completed, with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Status: COMPLETED | Results posted: 2015-12-09